Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Return on Invested Capital (2024 - 2025)

Historic Return on Invested Capital for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Q3 2025 value amounting to 0.38%.

  • Day One Biopharmaceuticals' Return on Invested Capital rose 1100.0% to 0.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.38%, marking a year-over-year increase of 1100.0%. This contributed to the annual value of 0.53% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Day One Biopharmaceuticals' Return on Invested Capital is 0.38%, which was up 1100.0% from 0.25% recorded in Q2 2025.
  • Day One Biopharmaceuticals' 5-year Return on Invested Capital high stood at 0.25% for Q2 2025, and its period low was 0.97% during Q2 2024.